About
Basic Data Updated:
4 months agoA portfolio of approximately 200 products catering to various therapeutic segments, including respiratory tract, anti allergy, neutraceuticals, hormonal, and others, is currently being manufactured by Corona Remedies Private Limited, a Gujarat-based pharmaceutical company. As per its credit rating report, the company's manufacturing unit is located in Solan, Himachal Pradesh. With a distribution network spanning over 10 states in India, CRPL is dedicated to providing quality formulations to its customers. The company operates five divisions, namely Pharma (specializing in gynaecology and pediatrics), Xenex (focusing on skin ailments and neurosurgery), Aarush (offering gynaecology and hormonal products, specifically catering to ethical/prescription drugs), and Ecogen and Aton (providing ov... Read More
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U24231GJ2004PTC044656 |
| Company No. | 044656 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 27 Aug 2004 |
| Date of AGM | 28 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Ahmedabad |
Products or Services related to Corona Remedies Private Limited
Antiepileptic Drugs
Diabetes Medicine
Antidiabetic Medicine
Anti Cancer Medicines
Financials of Corona Remedies Private Limited
Enhance accessibility to Corona Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Corona Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Corona Remedies Private Limited
Unlock and access historical data on people associated with Corona Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
BD
Bhagya Dave Company SecretaryStatus: Current
Board Members(6)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 07 Jul 2023 | ₹180.00 Cr | Open |
Others Creation Date: 28 Aug 2019 | ₹3.28 M | Satisfied |
Others Creation Date: 22 Aug 2019 | ₹6.06 M | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corona Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corona Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Jm Financial Asset Reconstruction Company Limited
Active
16 years 7 months Ameetkumar Desai is a mutual person
Adani Defence Systems And Technologies Limited
Active 9 years 1 month Ameetkumar Desai is a mutual person
Recent activity within the organization
Charges
A charge registered on 28 Aug 2012 via Charge ID 10377670 with State Bank Of India was fully satisfied on 18 Sep 2023.
18 Sep 2023Annual General Meeting
Corona Remedies Private Limited last Annual general meeting of members was held on 28 Aug 2023 as per latest MCA records.
28 Aug 2023Charges
A charge with Citi Bank N.A. amounted to Rs. 180.00 cr with Charge ID 100749708 was registered on 07 Jul 2023.
07 Jul 2023Balance Sheet
Corona Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
31 Mar 2023Director Appointment
Ameetkumar Hiranyakumar Desai was appointed as a Director was appointed as a Director on 22 Nov 2022 & has been associated with this company since 1 year 5 months .
22 Nov 2022
Recent News, Updates & Announcement
Corona Acquires Myoril from Sanofi India for Rs234 Crore Boosting Indian Pharma Industrys Growth.CORONA Remedies bought Myoril from Sanofi India for Rs234 crore Sanofi sold it to focus on chronic diseases Corona also bought other brands before Myoril is worth Rs38 crore and growing at 68 Sanofi also sold other brands to different companies Indian pharma industry is growing at 10 and expected to reach Rs295100 crore by 2026 Epharmacy and new regulations will help it grow.
Economic Times 29 Jun 2023
- CORONA Remedies joins hands with Ferring Pharmaceuticals to commercialize Maternal Health Urology products in India ANI.
Asian News International 09 May 2023
- Corona Remedies joins hands with Ferring Pharma to commercialise maternal health urology products in India.
BioSpectrum India 06 May 2023
- Company watch Creadorbacked Corona Remedies looks to pop a profit pill.
VCCircle 10 Sep 2018
- Corona Remedies acquires two brands from Abbott.
Both the brands are popular prescription drugs to manage diabetes and hyperthyroidism Tejas Kothari HeadStrategy at Corona said.
PTI 02 Apr 2018
Frequently asked questions
What is the Incorporation or founding date of Corona Remedies Private Limited?
